Basic Information
| LncRNA/CircRNA Name | ADAMTS9-AS2 |
| Synonyms | lncADAMTS9-AS2 |
| Region | GRCh38_3:64684909-65011468 |
| Ensemble | ENSG00000241684 |
| Refseq | NR_038264 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | breast cancer |
| ICD-0-3 | C50 |
| Methods | qPCR |
| Sample | invasive ductal carcinoma (IDC) tissues |
| Expression Pattern | down-regulated |
| Function Description | We identified several antisense lncRNAs including ADAMTS9-AS2, EPB41L4A-AS1, WDFY3-AS2, FAM83H-AS1, ST8SIA6-AS1, CTB-92J24.3, and CTB-131K11.1.We observed significant downregulation of ADAMTS9-AS2, WDFY3-AS2, RP11-295M3.4, RP11-490M8.1, and CTB-92J24.3 and significant overexpression of FAM83H-AS1 in breast cancer. |
| Pubmed ID | 30959550 |
| Year | 2019 |
| Title | Identification of lncRNAs associated with early-stage breast cancer and their prognostic implications. |
External Links
| Links for ADAMTS9-AS2 | GenBank HGNC NONCODE |
| Links for breast cancer | OMIM COSMIC |